Sialic acid-modified nanomedicines modulate neutrophils for dual therapy of cancer and sepsis: addressing neglected sepsis comorbidities during cancer treatment

Yantong Li(Shenyang Pharmaceutical University), Yihui Deng(Shenyang Pharmaceutical University), Yanzhi Song(Shenyang Pharmaceutical University), Senyu Zhang(First Hospital of China Medical University), Jingyi Zhao(Shenyang Pharmaceutical University), Xinrong Liu(Xi'an Jiaotong University), Lin Lin(Harbin Medical University), Shuo Wang(Yanshan University), Tingyan Liu(Binzhou Medical University), Xinying Guan(Shenyang Pharmaceutical University), Mingze Li(Shenyang Pharmaceutical University), Rui Yang(Tianjin University of Science and Technology)
International Journal of Pharmaceutics
January 10, 2025
Cited by 5


Related Papers